Market Overview

Sang Lucci Pre-Market Update January 9th

Related BAC
Mid-Afternoon Market Update: NASDAQ Up 2.5%; Jeld-Wen Holding Shares Plunge
Gold Finally Behaved Like Gold Last Week
Bank Of America: When The Dust Settles, This Bank Is Still A Buy (Seeking Alpha)

Markets are positive this morning after an upbeat earnings report from Alcoa (NYSE: AA). That name unofficially kicks off the earnings season so most investors watch it to provide them with a gauge for the whole season. Of course, it's a bit premature to say all Q4 earnings will come in better than expected but it's at least a positive note that investors have used to justify adding more risk.

Bank of America (NYSE: BAC) got a downgrade this morning from Credit Suisse, citing that valuations have run up too high too quickly. Ironically, the $.10 cent sweep back to $12 at the close yesterday now looks like a setup by an insider who knew this news was coming out this morning. The other Financials haven't followed suit with BAC's weakness in the premarkets here so it may not be a sector-wide sell today.

Credit Cards are getting upgraded left and right after the Consumer Credit figures came out much higher than expected mostly due to student loans. Both Visa (NYSE: V) & Mastercard (NYSE: MA) are gapping to all time highs this morning.

Casinos are in the spotlight as well, with MGM (NYSE: MGM) being approved for a new casino in Macau. Las Vegas Sands (NYSE: LVS) continues its path to the heavens as well.
The market is toppy up here with the SPDR S&P 500 (NYSE: SPY) at $146 and because of the consolidation, you can see both sides of the spectrum playing out with a tug of war between the bulls and bears to figure out where the next break in the indexes will be. Some sectors are weak while others continue to remain bullish. We're seeing the indexes trade up and down with no real conviction as well making it difficult to hold daytrades for a decent period of time.

The strategy now has to be scalping until we get a clear direction from the markets.


The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

Posted-In: Options Markets Trading Ideas


Related Articles (AA + BAC)

View Comments and Join the Discussion!

Shares of Idenix Pharma Down 7+% After FDA Says Needs Added Time to Review Response Package for IDX184

Copper Seasonal LONG Bias: